Clinical Trial

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To compare the efficacy and safty of ABC-14 regimen with the traditional "3+7" regimen or AB-14 regimen in the treatment of newly diagnosed acute myeloid leukaemia
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-04.
Status change: Not Yet Recruiting → Recruiting 2025-11-14
Trial Details
NCT Number NCT06451861
Lead Sponsor Guangdong Provincial People's Hospital
Conditions Acute Myeloid Leukemia
Enrollment 240 participants
Start Date 2024-08-21
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-17